Effect of metformin adjunct therapy on cardiometabolic parameters in Indian adolescents with type 1 diabetes: a randomized controlled trial.
Shruti MondkarSukeshini KhandagaleNikhil ShahAnuradha KhadilkarChirantap OzaShital BhorKetan GondhalekarAneeta WagleNeha KajaleVaman KhadilkarPublished in: Frontiers in clinical diabetes and healthcare (2024)
Metformin as an adjunct to insulin in Asian Indian adolescents with T1D demonstrated beneficial effect on glycemic control, glycemic variability, IS, lipid profile, vascular function, weight and body fat, with a good safety profile when administered for 9 months.